These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23021944)

  • 1. Ligand properties and behaviours in an allosteric age.
    Langmead CJ
    Trends Pharmacol Sci; 2012 Dec; 33(12):621-2. PubMed ID: 23021944
    [No Abstract]   [Full Text] [Related]  

  • 2. Allosteric modulation of G protein-coupled receptors: perspectives and recent developments.
    Soudijn W; Van Wijngaarden I; IJzerman AP
    Drug Discov Today; 2004 Sep; 9(17):752-8. PubMed ID: 15450241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosteric modulators of rhodopsin-like G protein-coupled receptors: opportunities in drug development.
    Müller CE; Schiedel AC; Baqi Y
    Pharmacol Ther; 2012 Sep; 135(3):292-315. PubMed ID: 22728155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [G-protein-coupled receptors targeting: the allosteric approach].
    Sebag JA; Pantel J
    Med Sci (Paris); 2012 Oct; 28(10):845-51. PubMed ID: 23067415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G protein coupled receptors as allosteric proteins and the role of allosteric modulators.
    Kenakin T
    J Recept Signal Transduct Res; 2010 Oct; 30(5):313-21. PubMed ID: 20858023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric modulation of family C G-protein-coupled receptors: from molecular insights to therapeutic perspectives.
    Urwyler S
    Pharmacol Rev; 2011 Mar; 63(1):59-126. PubMed ID: 21228259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand detection in the allosteric world.
    Kenakin TP
    J Biomol Screen; 2010 Feb; 15(2):119-30. PubMed ID: 20086210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric agonists of 7TM receptors: expanding the pharmacological toolbox.
    Langmead CJ; Christopoulos A
    Trends Pharmacol Sci; 2006 Sep; 27(9):475-81. PubMed ID: 16889837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Allosteric modulator of GPCRs and new drug targets].
    Wei RS; He SP
    Sheng Li Ke Xue Jin Zhan; 2012 Dec; 43(6):459-62. PubMed ID: 23520767
    [No Abstract]   [Full Text] [Related]  

  • 10. Emerging opportunities for allosteric modulation of G-protein coupled receptors.
    Wang CI; Lewis RJ
    Biochem Pharmacol; 2013 Jan; 85(2):153-62. PubMed ID: 22975406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and characterization of orthosteric and allosteric muscarinic M2 acetylcholine receptor ligands by affinity selection-mass spectrometry.
    Whitehurst CE; Nazef N; Annis DA; Hou Y; Murphy DM; Spacciapoli P; Yao Z; Ziebell MR; Cheng CC; Shipps GW; Felsch JS; Lau D; Nash HM
    J Biomol Screen; 2006 Mar; 11(2):194-207. PubMed ID: 16490772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand binding and micro-switches in 7TM receptor structures.
    Nygaard R; Frimurer TM; Holst B; Rosenkilde MM; Schwartz TW
    Trends Pharmacol Sci; 2009 May; 30(5):249-59. PubMed ID: 19375807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When simple agonism is not enough: emerging modalities of GPCR ligands.
    Smith NJ; Bennett KA; Milligan G
    Mol Cell Endocrinol; 2011 Jan; 331(2):241-7. PubMed ID: 20654693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New concepts in drug discovery: collateral efficacy and permissive antagonism.
    Kenakin T
    Nat Rev Drug Discov; 2005 Nov; 4(11):919-27. PubMed ID: 16264435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unravelling multiple ligand-activation binding sites using RASSL receptors.
    Pauwels PJ
    Trends Pharmacol Sci; 2003 Oct; 24(10):504-7. PubMed ID: 14559400
    [No Abstract]   [Full Text] [Related]  

  • 16. G-protein-coupled receptors: from classical modes of modulation to allosteric mechanisms.
    Bridges TM; Lindsley CW
    ACS Chem Biol; 2008 Sep; 3(9):530-41. PubMed ID: 18652471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric properties of G protein-coupled receptor oligomers.
    Springael JY; Urizar E; Costagliola S; Vassart G; Parmentier M
    Pharmacol Ther; 2007 Sep; 115(3):410-8. PubMed ID: 17655934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for the identification of allosteric modulators of G-protein-coupled receptors.
    Burford NT; Watson J; Bertekap R; Alt A
    Biochem Pharmacol; 2011 Mar; 81(6):691-702. PubMed ID: 21184747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane signalling complexes: implications for development of functionally selective ligands modulating heptahelical receptor signalling.
    Piñeyro G
    Cell Signal; 2009 Feb; 21(2):179-85. PubMed ID: 18790047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand and decoy sets for docking to G protein-coupled receptors.
    Gatica EA; Cavasotto CN
    J Chem Inf Model; 2012 Jan; 52(1):1-6. PubMed ID: 22168315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.